OpenURL Connection Search

Select item for more details and to access through your institution.

Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.
Published in:
Oncogene, 2011, v. 30, n. 11, p. 1329, doi. 10.1038/onc.2010.515
By:
- Yang, L;
- Wang, H;
- Kornblau, S M;
- Graber, D A;
- Zhang, N;
- Matthews, J A;
- Wang, M;
- Weber, D M;
- Thomas, S K;
- Shah, J J;
- Zhang, L;
- Lu, G;
- Zhao, M;
- Muddasani, R;
- Yoo, S-Y;
- Baggerly, K A;
- Orlowski, R Z
Publication type:
Article
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 668, doi. 10.1038/bmt.2015.21
By:
- Kongtim, P;
- Qazilbash, M H;
- Shah, J J;
- Hamdi, A;
- Shah, N;
- Bashir, Q;
- Wang, M;
- Champlin, R;
- Manasanch, E E;
- Weber, D;
- Orlowski, R Z;
- Parmar, S
Publication type:
Article
Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 8, p. 1036, doi. 10.1038/bmt.2014.115
By:
- Parmar, S;
- Kongtim, P;
- Champlin, R;
- Dinh, Y;
- Elgharably, Y;
- Wang, M;
- Bashir, Q;
- Shah, J J;
- Shah, N;
- Popat, U;
- Giralt, S A;
- Orlowski, R Z;
- Qazilbash, M H
Publication type:
Article
Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 3, p. 465, doi. 10.1038/bmt.2013.209
By:
- Patel, K;
- Nusrat, M;
- Shah, N;
- Bashir, Q;
- Parmar, S;
- Shah, J;
- Thomas, S;
- Weber, D;
- Orlowski, R Z;
- Champlin, R;
- Qazilbash, M H
Publication type:
Article
Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 12, p. 1537, doi. 10.1038/bmt.2013.98
By:
- Sanchorawala, V;
- Hoering, A;
- Seldin, D C;
- Finn, K T;
- Fennessey, S A;
- Sexton, R;
- Mattar, B;
- Safah, H F;
- Holmberg, L A;
- Dean, R M;
- Orlowski, R Z;
- Barlogie, B
Publication type:
Article
The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma.
Published in:
British Journal of Cancer, 2014, v. 111, n. 3, p. 628, doi. 10.1038/bjc.2014.307
By:
- Wu, W;
- Merriman, K;
- Nabaah, A;
- Seval, N;
- Seval, D;
- Lin, H;
- Wang, M;
- Qazilbash, M H;
- Baladandayuthapani, V;
- Berry, D;
- Orlowski, R Z;
- Lee, M-H;
- Yeung, S-C J
Publication type:
Article
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma.
Published in:
Leukemia (08876924), 2015, v. 29, n. 9, p. 1945, doi. 10.1038/leu.2015.54
By:
- Shah, N;
- Thall, P F;
- Fox, P S;
- Bashir, Q;
- Shah, J J;
- Parmar, S;
- Lin, P;
- Kebriaei, P;
- Nieto, Y;
- Popat, U R;
- Hosing, C M;
- Cornelison, A;
- Shpall, E J;
- Orlowski, R Z;
- Champlin, R E;
- Qazilbash, M H
Publication type:
Article
Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.
Published in:
Leukemia (08876924), 2015, v. 29, n. 2, p. 515, doi. 10.1038/leu.2014.265
By:
- Yang, J;
- He, J;
- Wang, J;
- Cao, Y;
- Ling, J;
- Qian, J;
- Lu, Y;
- Li, H;
- Zheng, Y;
- Lan, Y;
- Hong, S;
- Matthews, J;
- Starbuck, M W;
- Navone, N M;
- Orlowski, R Z;
- Lin, P;
- Kwak, L W;
- Yi, Q
Publication type:
Article
Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy.
Published in:
Leukemia (08876924), 2014, v. 28, n. 5, p. 1129, doi. 10.1038/leu.2013.315
By:
- Thakurta, A;
- Gandhi, A K;
- Waldman, M F;
- Bjorklund, C;
- Ning, Y;
- Mendy, D;
- Schafer, P;
- Lopez-Girona, A;
- Lentzsch, S;
- Schey, S A;
- Calle, Y;
- Chelliah, R;
- Orlowski, R Z;
- Madan, A;
- Avet-Loiseau, H;
- Chopra, R
Publication type:
Article
Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications.
Published in:
Leukemia (08876924), 2014, v. 28, n. 2, p. 373, doi. 10.1038/leu.2013.174
By:
- Bjorklund, C C;
- Baladandayuthapani, V;
- Lin, H Y;
- Jones, R J;
- Kuiatse, I;
- Wang, H;
- Yang, J;
- Shah, J J;
- Thomas, S K;
- Wang, M;
- Weber, D M;
- Orlowski, R Z
Publication type:
Article
Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.
Published in:
Leukemia (08876924), 2012, v. 26, n. 9, p. 2114, doi. 10.1038/leu.2012.71
By:
- Yang, J;
- He, J;
- Wang, J;
- Cao, Y;
- Ling, J;
- Qian, J;
- Lu, Y;
- Li, H;
- Zheng, Y;
- Lan, Y;
- Hong, S;
- Matthews, J;
- Starbuck, M W;
- Navone, N M;
- Orlowski, R Z;
- Lin, P;
- Kwak, L W;
- Yi, Q
Publication type:
Article
Proteasome inhibitors in the treatment of multiple myeloma.
Published in:
2009
By:
- Shah, J. J.;
- Orlowski, R. Z.
Publication type:
journal article
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
Published in:
Leukemia (08876924), 2009, v. 23, n. 10, p. 1716, doi. 10.1038/leu.2009.122
By:
- Palumbo, A.;
- Sezer, O.;
- Kyle, R.;
- Miguel, J. S.;
- Orlowski, R. Z.;
- Moreau, P.;
- Niesvizky, R.;
- Morgan, G.;
- Comenzo, R.;
- Sonneveld, P.;
- Kumar, S.;
- Hajek, R.;
- Giralt, S.;
- Bringhen, S.;
- Anderson, K. C.;
- Richardson, P. G.;
- Cavo, M.;
- Davies, F.;
- Bladé, J.;
- Einsele, H.
Publication type:
Article

Found: 13